Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Gains from Sales and Divestitures (2024)

Historic Gains from Sales and Divestitures for CorMedix (CRMD) over the last 1 years, with Q4 2024 value amounting to $62241.0.

  • CorMedix's Gains from Sales and Divestitures changed N/A to $62241.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $62241.0, marking a year-over-year change of. This contributed to the annual value of $62241.0 for FY2024, which is N/A changed from last year.
  • As of Q4 2024, CorMedix's Gains from Sales and Divestitures stood at $62241.0.
  • CorMedix's 5-year Gains from Sales and Divestitures high stood at $62241.0 for Q4 2024, and its period low was $42844.0 during Q2 2024.